← All companies

BHST

BioHarvest Sciences Inc. Common Stock

BHST Nasdaq Pharmaceutical Preparations EDGAR ↗

$2.16

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$49.0M

Revenue (TTM)

$34.5M

Net income (TTM)

-$11.1M

EPS (TTM)

$-0.60

P/E ratio

—

Dividend yield

—

Free cash flow

-$9.58M

Cash

$23.0M

Total assets

—

Gross margin

—

52-week range

$1.82 – $12.80

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K REPORT Jul 29, 2026 6-K REPORT Jul 28, 2026 6-K REPORT Jul 16, 2026 6-K REPORT Jul 15, 2026 6-K REPORT Jun 18, 2026 6-K REPORT May 28, 2026 6-K REPORT May 14, 2026 6-K REPORT May 14, 2026 6-K REPORT May 14, 2026 6-K REPORT May 13, 2026 6-K REPORT May 12, 2026 6-K REPORT May 11, 2026 6-K REPORT May 1, 2026 6-K REPORT Apr 29, 2026 40-F BIOHARVEST SCIENCES INC. - FORM 40-F SEC FILING Mar 31, 2026 6-K REPORT Mar 27, 2026 6-K REPORT Mar 17, 2026 6-K REPORT Mar 16, 2026 6-K REPORT Mar 6, 2026 6-K REPORT Mar 5, 2026 6-K REPORT Mar 3, 2026 6-K REPORT Jan 7, 2026 6-K REPORT Dec 18, 2025 6-K REPORT Dec 3, 2025 6-K REPORT Nov 13, 2025 6-K REPORT Nov 12, 2025 6-K CURRENT REPORT Nov 10, 2025 6-K REPORT Nov 10, 2025 6-K REPORT Nov 4, 2025 6-K REPORT Oct 31, 2025 6-K REPORT Oct 31, 2025 6-K REPORT Sep 23, 2025 6-K REPORT Sep 22, 2025 6-K REPORT Sep 10, 2025 6-K REPORT Sep 9, 2025 6-K REPORT Sep 9, 2025 6-K REPORT Sep 2, 2025 6-K REPORT Aug 15, 2025 6-K REPORT Aug 13, 2025 6-K REPORT Aug 11, 2025